Aptamers are single-standard oligonucleotides or peptide molecules that bind to target molecules with high specificity and affinity. Aptamers contain complex secondary and tertiary structures that facilitate the formation of hydrogen bond and electrostatic interaction with target molecules. These offer high binding specificity to target molecules ranging from organic to inorganic molecules, peptides and viruses.
The global aptamers market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global aptamers market segmentation is based on product types (nucleic acid aptamers, peptide aptamers), applications (therapeutics development, diagnostics, molecular imaging, biomarker detection and discovery, research and development, biosensor and food safety).
The global aptamers market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global aptamers market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Geographically, the global aptamer market has been dominated by North America and Europe, followed by Asia Pacific region. The major players operating in the global aptamer market and included in this report are Aptagen, Inc., Aptamer Science, Inc., Base Pair Biotechnologies, Inc., Bioapter S.L., Aptamer Group and NOXXON Pharma AG.